Vida Clinical Studies (Site 1246), 5757 West Oklahoma Avenue — Milwaukee, Wisconsin

Vida Clinical Studies (Site 1246), 5757 West Oklahoma Avenue is a clinical research site located in Milwaukee, Wisconsin, United States 53219.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Vida Clinical Studies (Site 1246), 5757 West Oklahoma Avenue has participated in 1 clinical trials.

Therapeutic areas: Coronavirus, Covid19.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Milwaukee

Browse all research sites in Wisconsin · View every site in Milwaukee

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vida Clinical Studies (Site 1246), 5757 West Oklahoma Avenue?

Vida Clinical Studies (Site 1246), 5757 West Oklahoma Avenue has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vida Clinical Studies (Site 1246), 5757 West Oklahoma Avenue conducted?

Vida Clinical Studies (Site 1246), 5757 West Oklahoma Avenue has 1 clinical trials on record. Their work covers Coronavirus, Covid19.

Is Vida Clinical Studies (Site 1246), 5757 West Oklahoma Avenue accredited by Crixeo Clinical Trials?

Vida Clinical Studies (Site 1246), 5757 West Oklahoma Avenue has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vida Clinical Studies (Site 1246), 5757 West Oklahoma Avenue?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.